Skip to main content
Mark Truty, MD, General Surgery, Rochester, MN

Mark J Truty MD MSc, FACS

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)


Professor of Surgery. Chair - Division of Hepatobiliary and Pancreatic Surgery. Mayo Clinic Rochester

Join to View Full Profile
  • 200 1st St SWRochester, MN 55905

  • Phone+1 507-284-2166

  • Fax+1 507-284-5196

Dr. Truty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Surgical Oncology - Expertise in Pancreatic Cancer, Liver Cancer, Bile Duct Tumors, Gallbladder Cancer, Carcinoid and Neuroendocrine Tumors, Gastric Cancer, Sarcomas, and Intestinal Cancers. Specializing in advanced cancers (deemed unresectable/inoperable elsewhere). Willing to provide free-of-charge 2nd opinions and records review so patients can get definitive and honest answers on the appropriate treatment of their tumors.
  • For Medical Professionals - Improving care of patients with pancreatic cancer

    Effective chemotherapy, improved radiation and advanced surgical techniques form the basis of a multimodal team approach that has yielded promising results. Des

    Whipple procedure - Overview

    A Whipple procedure - also known as a pancreaticoduodenectomy - is a complex operation to remove the head of the pancreas, the first part of the small intestine

    Dr. Truty on Challenges With Treating Patients With Pancreatic Cancer

    Mark J. Truty, MD, MS, assistant professor of surgery, Mayo Clinic, discusses challenges with treating patients with pancreatic cancer.

    Surgery Is Becoming an Option for More Pancreatic Cancer Patients, Mayo Clinic E

    Pancreatic cancer has long proved the least survivable of the most common forms of cancer, however with new protocols many "inoperable" patients are living long

    Surgery for Advanced Pancreas Cancer - Mayo Clinic

    Mark Truty, M.D., a Mayo Clinic surgeon specialized in treatment of pancreatic cancer, discusses the evaluation, diagnosis, and treatment of pancreatic cancer.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2012
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Surgery, 2002 - 2009
  • Chicago Medical School
    Chicago Medical SchoolMSc, Pathology, 1999 - 2002
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2002
  • Chicago Medical School
    Chicago Medical SchoolMSc, Physiology, 1998 - 1999
  • University of Chicago
    University of ChicagoBA, Biological Sciences, 1991 - 1995

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2003 - 2025
  • TX State Medical License
    TX State Medical License 2009 - 2013
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Lectures

  • Taking Locally Advanced Pancreas Cancer to the Operating Room—Who, When, and How? 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Authored Content

  • Indications and Perioperative Outcomes for Pancreatectomy with Arterial ResectionMay 2018

Press Mentions

  • Measurement of Mutant KRAS ctDNA Predicts Pancreatic Cancer Outcomes
    Measurement of Mutant KRAS ctDNA Predicts Pancreatic Cancer OutcomesMarch 26th, 2025
  • Measurement of Mutant KRAS ctDNA Predicts Pancreatic Cancer Outcomes
    Measurement of Mutant KRAS ctDNA Predicts Pancreatic Cancer OutcomesMarch 26th, 2025
  • Genetic Mutation Predicts Pancreatic Cancer Metastasis and Survival
    Genetic Mutation Predicts Pancreatic Cancer Metastasis and SurvivalMarch 19th, 2025
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: